BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 29169908)

  • 1. Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry.
    Gaertner S; Cordeanu EM; Mirea C; Frantz AS; Auger C; Bilbault P; Ohlmann P; Schini-Kerth V; Stephan D
    Int J Cardiol; 2018 Feb; 252():169-174. PubMed ID: 29169908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
    Golemi I; Cote L; Iftikhar O; Brenner B; Tafur A; Bikdeli B; Fernández-Capitán C; Pedrajas JM; Otero R; Quintavalla R; Monreal M;
    J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):353-359.e1. PubMed ID: 31784355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence of Cancer after a Second Unprovoked Venous Thromboembolic Event.
    Rézig S; Mao RL; Couturaud F; Lacut K; Delluc A
    Thromb Haemost; 2019 Mar; 119(3):490-495. PubMed ID: 30685873
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Conundrum of Occult Cancer Screening in Venous Thromboembolism: Lessons from the REMOTEV Registry.
    Cordeanu EM; Jambert L; Tousch J; Mirea C; Delatte A; Younes W; Woehl B; Harter C; Frantz AS; Hamade A; Schini-Kerth V; Ohlmann P; Andres E; Stephan D
    Medicina (Kaunas); 2022 Jul; 58(7):. PubMed ID: 35888632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary embolism risk stratification by European Society of Cardiology is associated with recurrent venous thromboembolism: Findings from a long-term follow-up study.
    Zhang S; Zhai Z; Yang Y; Zhu J; Kuang T; Xie W; Yang S; Liu F; Gong J; Shen YH; Wang C
    Int J Cardiol; 2016 Jan; 202():275-81. PubMed ID: 26408837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Traditional Cardiovascular Risk Factors With Venous Thromboembolism: An Individual Participant Data Meta-Analysis of Prospective Studies.
    Mahmoodi BK; Cushman M; Anne Næss I; Allison MA; Bos WJ; Brækkan SK; Cannegieter SC; Gansevoort RT; Gona PN; Hammerstrøm J; Hansen JB; Heckbert S; Holst AG; Lakoski SG; Lutsey PL; Manson JE; Martin LW; Matsushita K; Meijer K; Overvad K; Prescott E; Puurunen M; Rossouw JE; Sang Y; Severinsen MT; Ten Berg J; Folsom AR; Zakai NA
    Circulation; 2017 Jan; 135(1):7-16. PubMed ID: 27831499
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-Term Effects of Unprovoked Venous Thromboembolism on Mortality and Major Cardiovascular Events.
    Chang WT; Chang CL; Ho CH; Hong CS; Wang JJ; Chen ZC
    J Am Heart Assoc; 2017 May; 6(5):. PubMed ID: 28468786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors of arterial thrombotic events after unprovoked venous thromboembolism, and after cancer associated venous thromboembolism: A prospective cohort study.
    Noumegni SR; Didier R; Mansourati V; Tromeur C; Le Moigne E; Hoffmann C; Nasr B; Gentric JC; Guegan M; Poulhazan E; Lacut K; Bressollette L; Le Mao R; Couturaud F
    Thromb Res; 2022 Jun; 214():93-105. PubMed ID: 35525202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rivaroxaban versus standard anticoagulation for symptomatic venous thromboembolism (REMOTEV observational study): Analysis of 6-month outcomes.
    Gaertner S; Cordeanu EM; Nouri S; Faller AM; Frantz AS; Mirea C; Bilbault P; Ohlmann P; Le Ray I; Stephan D
    Int J Cardiol; 2017 Jan; 226():103-109. PubMed ID: 27806307
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
    Cavallari I; Morrow DA; Creager MA; Olin J; Bhatt DL; Steg PG; Storey RF; Cohen M; Scirica BS; Piazza G; Goodrich EL; Braunwald E; Sabatine MS; Bonaca MP
    Circulation; 2018 Feb; 137(7):684-692. PubMed ID: 29084737
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome after discontinuing anticoagulant therapy in women with venous thromboembolism during hormonal use.
    Blanco-Molina Á; Trujillo-Santos J; Pesavento R; Rosa V; Falgá C; Tolosa C; Mazzolai L; Sampériz Á; Duce R; Monreal M;
    Thromb Res; 2017 Mar; 151 Suppl 1():S6-S10. PubMed ID: 28262237
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrent venous thromboembolism after pregnancy-associated versus unprovoked thromboembolism.
    White RH; Chan WS; Zhou H; Ginsberg JS
    Thromb Haemost; 2008 Aug; 100(2):246-52. PubMed ID: 18690344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unprovoked venous thromboembolism and subsequent cancer risk: a population-based cohort study.
    Sun LM; Chung WS; Lin CL; Liang JA; Kao CH
    J Thromb Haemost; 2016 Mar; 14(3):495-503. PubMed ID: 26748492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Family history of myocardial infarction and cause-specific risk of myocardial infarction and venous thromboembolism: the Tromsø Study.
    Lind C; Enga KF; Mathiesen EB; Njølstad I; Brækkan SK; Hansen JB
    Circ Cardiovasc Genet; 2014 Oct; 7(5):684-91. PubMed ID: 25087051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of first and recurrent venous thromboembolism: a population-based cohort study in patients without active cancer.
    Martinez C; Cohen AT; Bamber L; Rietbrock S
    Thromb Haemost; 2014 Aug; 112(2):255-63. PubMed ID: 24695909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epidemiology and pathophysiology of venous thromboembolism: similarities with atherothrombosis and the role of inflammation.
    Riva N; Donadini MP; Ageno W
    Thromb Haemost; 2015 Jun; 113(6):1176-83. PubMed ID: 25472800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between red cell distribution width and risk of venous thromboembolism.
    Bucciarelli P; Maino A; Felicetta I; Abbattista M; Passamonti SM; Artoni A; Martinelli I
    Thromb Res; 2015 Sep; 136(3):590-4. PubMed ID: 26220270
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E-selectin and sICAM-1, biomarkers of endothelial function, predict recurrence of venous thromboembolism.
    Dzikowska-Diduch O; Domienik-Karłowicz J; Górska E; Demkow U; Pruszczyk P; Kostrubiec M
    Thromb Res; 2017 Sep; 157():173-180. PubMed ID: 28780342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamics of case-fatalilty rates of recurrent thromboembolism and major bleeding in patients treated for venous thromboembolism.
    Lecumberri R; Alfonso A; Jiménez D; Fernández Capitán C; Prandoni P; Wells PS; Vidal G; Barillari G; Monreal M;
    Thromb Haemost; 2013 Oct; 110(4):834-43. PubMed ID: 23846721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and outcomes of patients with multiple simultaneous superficial vein thrombi.
    Chopra R; Leon LR; Labropoulos N
    J Vasc Surg Venous Lymphat Disord; 2018 Jul; 6(4):485-491. PubMed ID: 29678687
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.